C12Y 102/04004
3-methyl-2-oxobutanoate dehydrogenase , i.e. branched-chain-alpha-ketoacid dehydrogenase
Official title: 3-Methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) (1.2.4.4), i.e. branched-chain-alpha-ketoacid dehydrogenase
C12Y102/04004 (3-methyl-2-oxobutanoate dehydrogenase , i.e. branched-chain-alpha-ketoacid dehydrogenase) appears on 28 US grants and 36 published applications in this corpus.
Search patents in C12Y- Granted patents
- 28
- Published applications
- 36
- Assignees
- 22
- Inventors
- 83
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 2 |
| 2011 | 1 | 4 |
| 2012 | 2 | 0 |
| 2013 | 0 | 2 |
| 2014 | 2 | 4 |
| 2015 | 3 | 4 |
| 2016 | 6 | 1 |
| 2017 | 0 | 2 |
| 2018 | 2 | 1 |
| 2019 | 0 | 3 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 2 | 3 |
| 2023 | 0 | 2 |
| 2024 | 1 | 1 |
| 2025 | 2 | 1 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Polynucleotides encoding branched-chain alpha-ketoacid dehydrogenase complex E1-α, E1-β, and E2 subunits for the treatment of maple syrup urine disease2 Jun 2026US 12,644,102 B2ModernaTX, Inc.
- AAV-mediated gene therapy for maple syrup urine disease (MSUD)26 Aug 2025US 12,398,378 B2The Clinic for Special Children, Inc.
- Methods and microorganisms for the fermentation of methane to multi-carbon compounds25 Feb 2025US 12,234,465 B2Precigen, Inc.
- Process for the production of methyl methacrylate14 May 2024US 11,981,951 B2Mitsubishi Chemical UK Limited
- Methods and microorganisms for the fermentation of methane to multi-carbon compounds23 Aug 2022US 11,421,235 B2Precigen, Inc.
- Isolated mitochondria as delivery vehicles and stimulators of protein synthesis17 Sep 2026US 2026/0272971 A1Minovia Therapeutics Ltd.
- Aav-mediated gene therapy for maple syrup urine disease (msud)10 Sep 2026US 2026/0265704 A1The Clinic for Special Children, Inc.
- Production of cannabinoids and engineered cells therefor23 Jul 2026US 2026/0209780 A1Cellibre, Inc.
- Aav-mediated gene therapy for maple syrup urine disease (msud)5 Mar 2026US 2026/0062682 A1The Clinic for Special Children, Inc.
- Methods and microorganisms for the fermentation of methane to multi-carbon compounds18 Dec 2025US 2025/0382623 A1
Most cited
By later US patents
- Fermentive production of four carbon alcohols125US 7,851,188 B2Butamax(Tm) Advanced Biofuels LLC · 2010
- Fermentive production of four carbon alcohols84US 7,993,889 B1Butamax(Tm) Advanced Biofuels LLC · 2011
- Fermentive production of four carbon alcohols55US 8,178,328 B2Butamax(Tm) Advanced Biofuels LLC · 2012
- Fermentive production of four carbon alcohols48US 8,283,144 B2Butamax(Tm) Advanced Biofuels LLC · 2012
- Fermentive production of four carbon alcohols43US 8,735,114 B2Butamax(Tm) Advanced Biofuels LLC · 2014